Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection

The incidence of heart failure and chronic kidney disease is increasing, and many patients develop both diseases. Angiotensin receptor‐neprilysin inhibitor (ARNI) is a promising therapeutic candidate for both diseases. ARNI has demonstrated superior cardioprotective effects compared with renin–angio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Shunichiro, Uehara, Tatsuki, Azushima, Kengo, Wakui, Hiromichi, Tamura, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Contemporary Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227251/
https://www.ncbi.nlm.nih.gov/pubmed/37066800
http://dx.doi.org/10.1161/JAHA.122.029565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227251/
https://www.ncbi.nlm.nih.gov/pubmed/37066800
http://dx.doi.org/10.1161/JAHA.122.029565

Ejemplares similares